ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

CINRYZE
Hereditary angioedema
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

CINRYZE Rx

Generic Name and Formulations:
C1 inhibitor (human) 500 Units/vial; lyophilized pwd for IV infusion after reconstitution; preservative-free.

Company:
Shire US, Inc.

Therapeutic Use:

Indications for CINRYZE:

Routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE).

Adult:

Give by IV infusion at a rate of 1mL/min (10mins). 1000 Units every 3–4 days.

Children:

Not recommended.

Warnings/Precautions:

Contains human plasma; monitor for possible infection transmission. Have epinephrine available to treat hypersensitivity reactions. Monitor patients with known risk factors for thrombotic events. Labor & delivery. Pregnancy (Cat.C). Nursing mothers.

Pharmacological Class:

C1 inhibitor.

Adverse Reactions:

Upper respiratory tract infection, sinusitis, rash, headache; thrombotic events, hypersensitivity reactions (may be severe); discontinue if occurs.

Note:

To report infections that may have been transmitted by Cinryze, call CinryzeSolutions at (877) 945-1000.

Generic Availability:

NO

How Supplied:

Single-use vial—1

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs